Yasunari Takakuwa
Research Subjects
Yasunari Takakuwa has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Ai Shimizu
Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan
1 shared publication Akio Homma
Department of Urology Moriyama Hospital Asahikawa Japan
1 shared publication- Akira Suzuki
Department of Pathology, KKR Sapporo Medical Center, Sapporo 062-0931, Japan
1 shared publication - Azusa Kawaguchi
Department of Pediatrics, National Hospital Organization Hokkaido Medical Center, Sapporo, Hokkaido, Japan
1 shared publication - Daisuke Takahashi
Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan
1 shared publication - Emi Takakuwa
Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan
1 shared publication
Latest Publications
- Open Access
- 3 September 2026
- Published by Wiley in IJU Case Reports
- Vol. 9 (5) , e70257
Mesothelioma of the Tunica Vaginalis Testis Initially Treated as Hydrocele: A Case Report
Introduction: Herein, we report a case of mesothelioma of the tunica vaginalis testis (MTVT), treated as a hydrocele. Case Presentation: A 65‐year‐old man was referred to our hospital after MTVT was incidentally diagnosed during hydrocelectomy performed for recurrent hydrocele. Left hemiscrotectomy was performed, and pathological examination revealed an epithelioid‐type MTVT with invasion into the testis and spermatic cord. Immunohistochemistry was positive for D2‐40 and calretinin, and negative for cytokeratin 5/6 and carcinoembryonic antigen. The patient remained disease‐free for 12 months postoperatively without adjuvant treatment. Conclusion: MTVT should be considered in patients with long‐standing or recurrent hydrocele. Wide surgical excision is essential for local control.
- 3 September 2026
- Published by Wiley in IJU Case Reports
- Vol. 9 (5) , e70257
Open AccessMesothelioma of the Tunica Vaginalis Testis Initially Treated as Hydrocele: A Case Report
Introduction: Herein, we report a case of mesothelioma of the tunica vaginalis testis (MTVT), treated as a hydrocele. Case Presentation: A 65‐year‐old man was referred to our hospital after MTVT was incidentally diagnosed during hydrocelectomy performed for recurrent hydrocele. Left hemiscrotectomy was performed, and pathological examination revealed an epithelioid‐type MTVT with invasion into the testis and spermatic cord. Immunohistochemistry was positive for D2‐40 and calretinin, and negative for cytokeratin 5/6 and carcinoembryonic antigen. The patient remained disease‐free for 12 months postoperatively without adjuvant treatment. Conclusion: MTVT should be considered in patients with long‐standing or recurrent hydrocele. Wide surgical excision is essential for local control.
- 25 August 2026
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 34 (5)
A Study of 28 Pediatric Patients With Drug Crystals Following Tosufloxacin Administration
Background: Tosufloxacin (TFLX) is an oral fluoroquinolone antibiotic that has been reported to cause crystalluria and acute kidney injury. To clarify the clinical course of drug crystals after TFLX administration in children, we conducted a retrospective review of pediatric patients who developed drug crystals after receiving TFLX. Methods: This retrospective study included 28 pediatric patients aged 15 years or younger who were treated in the Department of Pediatrics at NTT Medical Center Sapporo, Japan, between January 1, 2016, and March 31, 2026, and in whom drug crystals were detected in urine sediment after TFLX administration. Results: The median age of the patients at diagnosis was 6.5 years (interquartile range: 4.4 to 8.2 y), and 11 patients (39%) were male. The median time to diagnosis after TFLX administration was 2 days (interquartile range: 1 to 3 d). Gastrointestinal symptoms, such as vomiting and abdominal pain, were observed in 6 patients (21%), and decreased appetite was observed in 3 patients (11%). All patients who had a known dosage received an appropriate dose of TFLX. Ten patients (36%) were diagnosed with acute kidney injury, and they improved within 3 to 5 days after discontinuing TFLX and replacing fluids. Conclusions: Despite the administration of the appropriate TFLX dosage, drug crystals were observed in the urine sediment 1 to 4 days after administration. When administering TFLX, it is important to be aware that drug crystals and acute kidney injury may occur. Discontinuing the drug can prevent progression of kidney injury.
- 25 August 2026
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 34 (5)
A Study of 28 Pediatric Patients With Drug Crystals Following Tosufloxacin Administration
Background: Tosufloxacin (TFLX) is an oral fluoroquinolone antibiotic that has been reported to cause crystalluria and acute kidney injury. To clarify the clinical course of drug crystals after TFLX administration in children, we conducted a retrospective review of pediatric patients who developed drug crystals after receiving TFLX. Methods: This retrospective study included 28 pediatric patients aged 15 years or younger who were treated in the Department of Pediatrics at NTT Medical Center Sapporo, Japan, between January 1, 2016, and March 31, 2026, and in whom drug crystals were detected in urine sediment after TFLX administration. Results: The median age of the patients at diagnosis was 6.5 years (interquartile range: 4.4 to 8.2 y), and 11 patients (39%) were male. The median time to diagnosis after TFLX administration was 2 days (interquartile range: 1 to 3 d). Gastrointestinal symptoms, such as vomiting and abdominal pain, were observed in 6 patients (21%), and decreased appetite was observed in 3 patients (11%). All patients who had a known dosage received an appropriate dose of TFLX. Ten patients (36%) were diagnosed with acute kidney injury, and they improved within 3 to 5 days after discontinuing TFLX and replacing fluids. Conclusions: Despite the administration of the appropriate TFLX dosage, drug crystals were observed in the urine sediment 1 to 4 days after administration. When administering TFLX, it is important to be aware that drug crystals and acute kidney injury may occur. Discontinuing the drug can prevent progression of kidney injury.
- Open Access
- 28 May 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (11) , 1115
Evaluating Cellularity Estimation Methods: Comparing AI Counting with Pathologists’ Visual Estimates
The development of next-generation sequencing (NGS) has enabled the discovery of cancer-specific driver gene alternations, making precision medicine possible. However, accurate genetic testing requires a sufficient amount of tumor cells in the specimen. The evaluation of tumor content ratio (TCR) from hematoxylin and eosin (H&E)-stained images has been found to vary between pathologists, making it an important challenge to obtain an accurate TCR. In this study, three pathologists exhaustively labeled all cells in 41 regions from 41 lung cancer cases as either tumor, non-tumor or indistinguishable, thus establishing a “gold standard” TCR. We then compared the accuracy of the TCR estimated by 13 pathologists based on visual assessment and the TCR calculated by an AI model that we have developed. It is a compact and fast model that follows a fully convolutional neural network architecture and produces cell detection maps which can be efficiently post-processed to obtain tumor and non-tumor cell counts from which TCR is calculated. Its raw cell detection accuracy is 92% while its classification accuracy is 84%. The results show that the error between the gold standard TCR and the AI calculation was significantly smaller than that between the gold standard TCR and the pathologist’s visual assessment (). Additionally, the robustness of AI models across institutions is a key issue and we demonstrate that the variation in AI was smaller than that in the average of pathologists when evaluated by institution. These findings suggest that the accuracy of tumor cellularity assessments in clinical workflows is significantly improved by the introduction of robust AI models, leading to more efficient genetic testing and ultimately to better patient outcomes.- 28 May 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (11) , 1115
Open AccessEvaluating Cellularity Estimation Methods: Comparing AI Counting with Pathologists’ Visual Estimates
The development of next-generation sequencing (NGS) has enabled the discovery of cancer-specific driver gene alternations, making precision medicine possible. However, accurate genetic testing requires a sufficient amount of tumor cells in the specimen. The evaluation of tumor content ratio (TCR) from hematoxylin and eosin (H&E)-stained images has been found to vary between pathologists, making it an important challenge to obtain an accurate TCR. In this study, three pathologists exhaustively labeled all cells in 41 regions from 41 lung cancer cases as either tumor, non-tumor or indistinguishable, thus establishing a “gold standard” TCR. We then compared the accuracy of the TCR estimated by 13 pathologists based on visual assessment and the TCR calculated by an AI model that we have developed. It is a compact and fast model that follows a fully convolutional neural network architecture and produces cell detection maps which can be efficiently post-processed to obtain tumor and non-tumor cell counts from which TCR is calculated. Its raw cell detection accuracy is 92% while its classification accuracy is 84%. The results show that the error between the gold standard TCR and the AI calculation was significantly smaller than that between the gold standard TCR and the pathologist’s visual assessment (). Additionally, the robustness of AI models across institutions is a key issue and we demonstrate that the variation in AI was smaller than that in the average of pathologists when evaluated by institution. These findings suggest that the accuracy of tumor cellularity assessments in clinical workflows is significantly improved by the introduction of robust AI models, leading to more efficient genetic testing and ultimately to better patient outcomes. - Open Access
- 30 March 2020
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 53 (2) , 206-212
Efficacy and Safety of Complete Endoscopic Resection of Colorectal Neoplasia Using a Stepwise Endoscopic Protocol with SOUTEN, a Novel Multifunctional Snare
A multifunctional snare SOUTEN has a sharp tip at the top of the snare loop that enables incision of the mucosa, dissection of the submucosal layer, and snaring of lesion. This study assessed the efficacy and safety of complete endoscopic resection of colorectal neoplasia using SOUTEN. We analyzed the rates of gross en bloc resection and complete resections of 108 consecutive tumors from 69 patients resected by precutting endoscopic mucosal resection (precutting), hybrid endoscopic submucosal dissection (hybrid), or conventional endoscopic submucosal dissection (conventional) using SOUTEN. Out of the 108 tumors, 50 were resected by precutting, 27 were resected by hybrid after attempting precutting, and the remaining 31 were resected by conventional after attempting precutting and hybrid resections. The median tumor sizes were 14.5 mm for precutting, 16.4 mm for hybrid, and 21.1 mm for conventional. The success rate of gross en bloc resection and histological complete resection were 100% and 94.0% for precutting, 96.4% and 96.4% for hybrid, and 100% and 100% for conventional method, respectively. No procedure-related complication occurred. By using SOUTEN, precutting and hybrid were successfully performed on 10-30 mm tumors with a shorter procedure time than conventional without major complications.
- 30 March 2020
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 53 (2) , 206-212
Open AccessEfficacy and Safety of Complete Endoscopic Resection of Colorectal Neoplasia Using a Stepwise Endoscopic Protocol with SOUTEN, a Novel Multifunctional Snare
A multifunctional snare SOUTEN has a sharp tip at the top of the snare loop that enables incision of the mucosa, dissection of the submucosal layer, and snaring of lesion. This study assessed the efficacy and safety of complete endoscopic resection of colorectal neoplasia using SOUTEN. We analyzed the rates of gross en bloc resection and complete resections of 108 consecutive tumors from 69 patients resected by precutting endoscopic mucosal resection (precutting), hybrid endoscopic submucosal dissection (hybrid), or conventional endoscopic submucosal dissection (conventional) using SOUTEN. Out of the 108 tumors, 50 were resected by precutting, 27 were resected by hybrid after attempting precutting, and the remaining 31 were resected by conventional after attempting precutting and hybrid resections. The median tumor sizes were 14.5 mm for precutting, 16.4 mm for hybrid, and 21.1 mm for conventional. The success rate of gross en bloc resection and histological complete resection were 100% and 94.0% for precutting, 96.4% and 96.4% for hybrid, and 100% and 100% for conventional method, respectively. No procedure-related complication occurred. By using SOUTEN, precutting and hybrid were successfully performed on 10-30 mm tumors with a shorter procedure time than conventional without major complications.
- Open Access
- 19 February 2019
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 20 (1) , 1-4
Corticosteroid dose increase is a risk factor for nonalcoholic fatty liver disease and contralateral osteonecrosis of the femoral head: a case report
The incidence of bilateral corticosteroid-induced osteonecrosis of the femoral head (ONFH) is high. Although the precise mechanism of corticosteroid-induced ONFH development is unclear, hepatic enzyme abnormalities such as low activity of hepatic cytochrome P450 3A could be one cause. Herein, we report the case of a patient who developed ONFH in the contralateral hip after the dose of corticosteroids for idiopathic thrombocytopenic purpura was increased. Liver biopsy was done to rule out autoimmune hepatitis. A 32-year-old woman had been treated with continuous corticosteroids of up to 10 mg/day for Sjögren’s syndrome for 25 years and corticosteroid-induced ONFH in the left side. At age 33, idiopathic thrombocytopenia developed, which was treated by increasing the corticosteroid dose (40 mg/day). Two months later, liver enzyme level began to increase slightly and continued to increase. A year after corticosteroid dose increase, contralateral ONFH developed, and a liver biopsy demonstrated nonalcoholic fatty liver disease (NAFLD). The current case indicates that corticosteroid dose increase is a potential risk factor for NAFLD and contralateral ONFH. Therefore, it would be useful and important for to screen and monitor patients with hepatic enzyme abnormality for ONFH occurrence.
- 19 February 2019
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 20 (1) , 1-4
Open AccessCorticosteroid dose increase is a risk factor for nonalcoholic fatty liver disease and contralateral osteonecrosis of the femoral head: a case report
The incidence of bilateral corticosteroid-induced osteonecrosis of the femoral head (ONFH) is high. Although the precise mechanism of corticosteroid-induced ONFH development is unclear, hepatic enzyme abnormalities such as low activity of hepatic cytochrome P450 3A could be one cause. Herein, we report the case of a patient who developed ONFH in the contralateral hip after the dose of corticosteroids for idiopathic thrombocytopenic purpura was increased. Liver biopsy was done to rule out autoimmune hepatitis. A 32-year-old woman had been treated with continuous corticosteroids of up to 10 mg/day for Sjögren’s syndrome for 25 years and corticosteroid-induced ONFH in the left side. At age 33, idiopathic thrombocytopenia developed, which was treated by increasing the corticosteroid dose (40 mg/day). Two months later, liver enzyme level began to increase slightly and continued to increase. A year after corticosteroid dose increase, contralateral ONFH developed, and a liver biopsy demonstrated nonalcoholic fatty liver disease (NAFLD). The current case indicates that corticosteroid dose increase is a potential risk factor for NAFLD and contralateral ONFH. Therefore, it would be useful and important for to screen and monitor patients with hepatic enzyme abnormality for ONFH occurrence.